A Multi-Concept Theme for Digital Agencies and Startups
Ministry of Health and Family Welfare has issued a directive to ban the manufacture, sale, and distribution of the fixed dose combination drug Amylase + Protease + Glucoamylase + Pectinase + Alpha Galactosidase + Lactase + Beta-Gluconase + Cellulase + Lipase + Bromelain + Xylanase + Hemicellulase + Malt diastase + Invertase + Papain, Antimony Potassium Tartrate + Dried Ferrous Sulphate, Benfotiamine + Silymarin + L-Ornithine L-aspartate + Sodium Selenite + Folic acid + Pyridoxine hydrochloride, Bismuth Ammonium Citrate + Papain, Cyproheptadine HCl + Thiamine HCl + Riboflavine + Pyridoxine HCl + Niacinamide, Cyproheptadine Hydrochloride + Tricholine Citrate + Thiamine Hydrochloride + Riboflavine + Pyridoxine Hydrochloride, Rabeprazole Sodium (As enteric coated tablet) + Clidinium Bromide + Dicyclomine HCl + Chlordiazepoxide, Fungal Diastase + Papain + Nux vomica Tincture + Cardamom Tincture + Casein Hydrolysed + Alcohol, Mefenamic Acid + Paracetamol Injection, Omeprazole Magnesium + Dicyclomine HCl, S-adenosyl methionine + Metadoxine + Ursodeoxycholicacid BP + L-Methylfolate Calcium eq. to L-Methylfolate + Choline bitartratee + Silymarin + L-ornithine L-aspartate + Inositol + Taurine, Silymarin + Thiamine Mononitrate + Riboflavin+ Pyridoxine HCl + Niacinamide + Calcium pantothenate + Vitamin B12, Silymarin + Pyridoxine HCl + Cyanocobalamin + Niacinamide + Folic Acid, Silymarin + Vitamin B6 + Vitamin B12 + Niacinamide + Folic acid + Tricholine Citrate for human use. By virtue of the circular, this action is based on recommendations from the Drugs Technical Advisory Board and the powers granted under section 26A of the Drugs and Cosmetics Act, 1940. The drug is deemed to have no therapeutic benefit and may pose risks to human health. Please refer to the attached document for more details.
Request a Demo
The International Financial Services Centres Authority has notified the IFSCA (Electronic Trading Platforms) Regulations, 2026, establishing
CDSL has issued communique regarding on the Trading window closure (TWS) period for restricting trading by designated persons and immediate
BSE has issued circular regarding Compliance with TRAI directions and guidelines Through this circular, Trading Members are advised to note
CDSL has issued communique regarding Introduction of OTP-Based authentication for physical BO modification request Through this communique
The Food Safety and Standards Authority of India has notified the Food Safety and Standards (Laboratory and Sample Analysis) Amendment Regul
The Tamil Nadu Town and Country Planning (Amendment) Act, 2026 amends provisions relating to the constitution of the Town and Country Planni
The Tamil Nadu Panchayats (Second Amendment) Act, 2026 extends the validity of the provisions relating to Special Officers appointed to exer
The Bureau of Indian Standards has issued Indian Standards with their date of establishment with date of withdrawal of previous standards. T
Thank You for your interest in Complinity. Your CV has been forwarded to HR. In case your profile is shortlisted, HR shall contact you.
Thank You for your interest in Complinity. Your CV has been forwarded to HR.